Literature DB >> 19956087

Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.

José A Morón1, Srinivas Gullapalli, Chirisse Taylor, Achla Gupta, Ivone Gomes, Lakshmi A Devi.   

Abstract

Opiate addiction is a chronic, relapsing behavioral disorder where learned associations that develop between the abused opiate and the environment in which it is consumed are brought about through Pavlovian (classical) conditioning processes. However, the signaling mechanisms/pathways regulating the mechanisms that underlie the responses to opiate-associated cues or the development of sensitization as a consequence of repeated context-independent administration of opiates are unknown. In this study we examined the phosphorylation levels of various classic signaling molecules in brain regions implicated in addictive behaviors after acute and repeated morphine administration. An unbiased place conditioning protocol was used to examine changes in phosphorylation that are associated with (1) the expression of the rewarding effects of morphine and (2) the sensitization that develops to this effect. We also examined the effects of a delta-receptor antagonist on morphine-induced conditioned behavior and on the phosphorylation of classic signaling molecules in view of data showing that blockade of delta-opioid receptor (deltaOR) prevents the development of sensitization to the rewarding effects of morphine. We find that CREB phosphorylation is specifically induced upon the expression of a sensitized response to morphine-induced conditioned behavior in brain areas related to memory consolidation, such as the hippocampus and cortex. A similar effect is also observed, albeit to a lesser extent, in the case of the GluR1 subunit of AMPA glutamate receptor. These increases in the phosphorylation levels of CREB and pGluR1 are significantly blocked by pretreatment with a deltaOR antagonist. These results indicate a critical role for phospho-CREB, AMPA, and deltaOR activities in mediating the expression of a sensitized response to morphine-dependent conditioned behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956087      PMCID: PMC2820136          DOI: 10.1038/npp.2009.199

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

Review 1.  Molecular neurobiology of addiction.

Authors:  E J Nestler
Journal:  Am J Addict       Date:  2001

Review 2.  Addiction and the brain: the neurobiology of compulsion and its persistence.

Authors:  S E Hyman; R C Malenka
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

Review 3.  Regulations of opioid dependence by opioid receptor types.

Authors:  M Narita; M Funada; T Suzuki
Journal:  Pharmacol Ther       Date:  2001-01       Impact factor: 12.310

4.  Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse.

Authors:  C L Walters; J A Blendy
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates.

Authors:  Lu Pu; Guo-Bin Bao; Nan-Jie Xu; Lan Ma; Gang Pei
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

6.  Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference.

Authors:  Devin Mueller; Dinos Perdikaris; Jane Stewart
Journal:  Behav Brain Res       Date:  2002-11-15       Impact factor: 3.332

7.  Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice.

Authors:  Y Zhu; M A King; A G Schuller; J F Nitsche; M Reidl; R P Elde; E Unterwald; G W Pasternak; J E Pintar
Journal:  Neuron       Date:  1999-09       Impact factor: 17.173

8.  Cerebellar defects in Ca2+/calmodulin kinase IV-deficient mice.

Authors:  T J Ribar; R M Rodriguiz; L Khiroug; W C Wetsel; G J Augustine; A R Means
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

9.  Dorsal/ventral hippocampus, fornix, and conditioned place preference.

Authors:  J Ferbinteanu; R J McDonald
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

Review 10.  Psychomotor stimulant addiction: a neural systems perspective.

Authors:  Barry J Everitt; Marina E Wolf
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

View more
  33 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit.

Authors:  Laura G Rosen; Jordan Zunder; Justine Renard; Jennifer Fu; Walter Rushlow; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

Review 3.  MicroRNAs in addiction: adaptation's middlemen?

Authors:  M D Li; A D van der Vaart
Journal:  Mol Psychiatry       Date:  2011-05-24       Impact factor: 15.992

4.  Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.

Authors:  H Beaudry; L Gendron; J A Morón
Journal:  Eur J Neurosci       Date:  2015-01-09       Impact factor: 3.386

5.  Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Authors:  Sophie K Billa; Yan Xia; Jose A Morón
Journal:  Eur J Neurosci       Date:  2010-07-09       Impact factor: 3.386

6.  Nortriptyline Enhances Morphine-Conditioned Place Preference in Neuropathic Rats: Role of the Central Noradrenergic System.

Authors:  Wenli Mi; Shuxing Wang; Zerong You; Grewo Lim; Michael F McCabe; Hyangin Kim; Lucy Chen; Jianren Mao
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

Review 7.  The delta opioid receptor: an evolving target for the treatment of brain disorders.

Authors:  Amynah A Pradhan; Katia Befort; Chihiro Nozaki; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Trends Pharmacol Sci       Date:  2011-09-17       Impact factor: 14.819

8.  Thioredoxin-1 was required for CREB activity by methamphetamine in rat pheochromocytoma cells.

Authors:  Tao Lv; Sheng-Dong Wang; Jie Bai
Journal:  Cell Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.046

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  Changes in the levels of p-ERK, p-CREB, and c-fos in rat mesocorticolimbic dopaminergic system after morphine-induced conditioned place preference: the role of acute and subchronic stress.

Authors:  Abbas Haghparast; Zahra Fatahi; Shabnam Zeighamy Alamdary; Zahra Reisi; Fariba Khodagholi
Journal:  Cell Mol Neurobiol       Date:  2013-12-01       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.